Immunopotentiation by immu 21 in immunocompromised rats

Area of Science:

• Immunology
• Pharmacology
• Natural Products

Background:

• Cytotoxic and immunosuppressive agents like cyclophosphamide and azathioprine can compromise the immune system.
• Assessing natural compounds for immunomodulatory effects is crucial for developing supportive therapies.
• The need for effective immunoadjuvants in clinical settings is significant.

Purpose of the Study:

• To evaluate the immunomodulatory efficacy of the polyherbal formulation IMMU-21.
• To determine if IMMU-21 can counteract immunosuppression induced by specific agents.
• To investigate the potential of IMMU-21 as an immunoadjuvant.

Main Methods:

• Animal models were used to assess IMMU-21's effects.
• Immunosuppression was induced using cyclophosphamide and azathioprine.
• Immune parameters including white blood cell counts and cell-mediated immunity were measured.

Main Results:

• IMMU-21 significantly minimized cyclophosphamide-induced leucopenia, lymphopenia, and neutropenia in rats.
• The polyherbal formulation enhanced host immune status against bacterial endotoxin.
• Cell-mediated immune responses were maintained at normal levels in immunocompromised mice treated with IMMU-21.

Conclusions:

• IMMU-21 demonstrates significant immunomodulatory and protective effects against immunosuppressive agents.
• The findings suggest IMMU-21 can strengthen the host immune system.
• IMMU-21 shows promise as a valuable immunoadjuvant with potential therapeutic applications.